Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Unionman Technology Co.,Ltd.
688609
5
Kingchem
301509
US Stock MarketDetailed Quotes
PEPG PepGen
- 1.440
- -0.150-9.43%
Close May 5 16:00 ET
47.12MMarket Cap-0.51P/E (TTM)
1.590High1.430Low137.82KVolume1.540Open1.590Pre Close202.62KTurnover1.31%Turnover RatioLossP/E (Static)32.72MShares19.29852wk High0.40P/B15.11MFloat Cap0.88052wk Low--Dividend TTM10.49MShs Float20.000Historical High--Div YieldTTM10.06%Amplitude0.880Historical Low1.470Avg Price1Lot Size
About PepGen Company
PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.
Company Profile
SymbolPEPG
Company NamePepGen
Listing DateMay 6, 2022
Issue Price12.00
Founded2018
CEOMr. James McArthur, PhD
MarketNASDAQ
Employees81
Fiscal Year Ends12-31
Address321 Harrison Avenue,8th Floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02118
Phone1-781-797-0979
Websitehttp://pepgen.com
Company Executives
- Name
- Position
- Salary
- James McArthur, PhD
- President, Chief Executive Officer and Director
- 4.43M
- Noel Donnelly, M.B.A.
- Chief Financial Officer and Principal Accounting Officer
- 2.35M
- Dr. Paul D. Streck
- Executive Vice President, Head of Research and Development
- --
- Laurie B. Keating, J.D.
- Chairman of the Board
- 244.39K
- Lisa Wyman
- Director
- --
- Dr. Mitchell H. Finer, PhD
- Director
- --
- Dr. Joshua Resnick, M.B.A.,M.D.
- Director
- 200.89K
- Heidi Henson, C.P.A.
- Independent Director
- 212.89K
- Habib Joseph Dable
- Independent Director
- 198.76K
- Dr. Howard Mayer, M.D.
- Independent Director
- 146.10K
- Mary Beth DeLena, J.D.
- General Counsel and Secretary
- --
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now